Coloplast AS (CLPBF) reports robust 8% organic growth and a 27% EBIT margin, while addressing challenges in Interventional ...

Brand new accessible bathroom facilities have been installed in a Telford community building thanks to funds raised by ...

Q1 2025. Management View. CEO Kristian Villumsen highlighted 8% organic growth and a reported EBIT margin of 27% for Q1 2025, w ...

December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported ...

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities. The below ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Tuesday, February 04 based on AAII’s Stock Grades.

It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions ...

Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 15.4% in the 4th quarter, HoldingsChannel.com reports. The ...

Discover the latest research on the management of venous leg ulcers. This Consensus Statement provides concise guidance for healthcare providers in Canada.